A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
Oncologist - United States
doi 10.1634/theoncologist.2015-0105
Full Text
Open PDFAbstract
Available in full text
Date
May 18, 2015
Authors
Publisher
Alphamed Press
Available in full text
May 18, 2015
Alphamed Press